Intavis Peptide Services is excited to participate in the Ninth International Cancer Immunotherapy Conference (CICON25), taking place from September 10th to 12th, 2025, at the Jaarbeurs Beatrix Theater in Utrecht, Netherlands.

Recognized as one of the premier global events in cancer immunology and immunotherapy, CICON25 brings together leading experts from academia, biotech, and pharma to translate cutting-edge research into transformative clinical outcomes.

What to expect at CICON25:

• State-of-the-art presentations on cancer immunotherapy innovations and clinical applications
• Insights into the latest developments in immune checkpoint modulation, vaccine design, and cell-based therapies
• Real-world case studies from pioneers advancing immunotherapy treatments
• Networking opportunities with decision-makers shaping the future of oncology and immune-based medicine

Whether you’re developing next-generation immunotherapies, exploring novel biomarker strategies, or seeking collaborations in oncology, CICON25 is the place to connect, share knowledge, and drive innovation.